<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Pharmacology - AIIMS MAY 2018</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`üß† Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Pharmacology - AIIMS MAY 2018</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                27 Questions | 27 Total Marks | 37 min Duration | ~82.22 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 27 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 37 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 27</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Pharmacology - AIIMS MAY 2018 - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 27</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 27 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "Which of the following drugs is not used in typhoid fever?", "options": [{"label": "A", "text": "Amikacin", "correct": true}, {"label": "B", "text": "Cefixime", "correct": false}, {"label": "C", "text": "Azithromycin", "correct": false}, {"label": "D", "text": "Ciprofloxacin", "correct": false}], "correct_answer": "A. Amikacin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Amikacin Amikacin is an antibiotic used to prevent or treat a wide variety of bacterial infections. These may include infections of the urinary tract, bones, and joints, lungs (eg. pneumonia), brain, blood, among others. It is also used in hospitalized patients to prevent infections.</p>\n<p><strong>Highyeild:</strong></p><p>Amikacin is a commonly used aminoglycoside. Antimicrobial spectrum of aminoglycosides does not include Salmonella. It is used in gentamicin and tobramycin resistant infections. It is used for organisms like Pseudomonas, Proteus, and Serratia. It is also effective in MDR-TB. Ciprofloxacin is the drug of choice (in fluoroquinolone-susceptible infection). Fluoroquinolones are considered by many experts to be the drug of choice for susceptible isolates. Of the fluoroquinolones, ciprofloxacin, and ofloxacin are widely available and effective. Norfloxacin is very poorly absorbed and should not be used. If a fluoroquinolone cannot be used, alternatives include azithromycin and third generation cephalosporins. Fluoroquinolone-nonsusceptible infection: When fluoroquinolones cannot be used, azithromycin can be used. If azithromycin cannot be used because of cost, availability, or other reasons, other options include third-generation cephalosporins and, if susceptibility is demonstrated, trimethoprim- sulfamethoxazole, amoxicillin, or chloramphenicol. Azithromycin has good efficacy for enteric fever. In a systematic review that included seven randomized trials of adults and children with enteric fever, azithromycin was at least as effective as comparators (fluoroquinolones, chloramphenicol, ceftriaxone). Among the third-generation cephalosporins, ceftriaxone may be superior to cefotaxime. Oral cefixime has not been extensively compared directly with ceftriaxone but appears to be of generally comparable efficacy. Cefixime for 14 days was comparable to azithromycin given for 7 days (93 versus 87 percent cure) in a study of children with uncomplicated enteric fever. Ceftriaxone is the treatment of choice for hospitalized patients.</p>\n<p><strong>Table:</strong></p><p>#MANTRA CLASSIFICATION Systemic Aminoglycosides >Streptomycin >Gentamicin >Kanamycin >Tobramycin > Amikacin > Sisomicin > Netilmicin > Paromomycin Topical Aminoglycosides >Neomycin >Framycetin</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A patient presented with history of few episodes of vomiting and was given an anti-emetic drug by the intern. Few hours later, the patient developed an abnormal posture. Which of the following is most likely drug administered to him?", "options": [{"label": "A", "text": "Metoclopramide", "correct": true}, {"label": "B", "text": "Ondansetron", "correct": false}, {"label": "C", "text": "Domperidone", "correct": false}, {"label": "D", "text": "Dexamethasone", "correct": false}], "correct_answer": "A. Metoclopramide", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Metoclopramide</p>\n<p><strong>Highyeild:</strong></p><p>This is a typical case of metoclopramide induced extrapyramidal side effect (EPS) in the form of Dystonia‚Äôs. Metoclopramide crosses BBB and blocks central D2 receptors. The major side effects of metoclopramide include EPS, such as those seen with the phenothiazine anti-psychotics. Dystonia usually occur acutely after intravenous administration and parkinsonian-like symptoms may occur several weeks after initiation of therapy. They generally respond to treatment with anticholinergic or antihistaminic drugs and are reversible upon discontinuation of metoclopramide. Tardive dyskinesia also can occur with chronic treatment (months to years) and may be irreversible. EPS appear to occur more commonly in children and young adults and at higher doses. Like other DA antagonists, metoclopramide also can cause galactorrhea by blocking the inhibitory effect of dopamine on prolactin release. Domperidone also blocks D2 receptors but it does not cross BBB, hence devoid of EPS. Ondansetron is a substance P antagonist used for chemotherapy induced nausea and vomiting. It does not block D2 receptors. Dexamethasone is a corticosteroid, used as an adjuvant for chemotherapy induced vomiting. It does not have any effect on D2 receptors.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Class Drugs Site of action Prokinetics Metochlopramide Domperidone Prochlorperazine D2 receptors Serotonin antagonists Ondansetron Granisetron Ramosetron Palonosetron 5HT-3 receptors Antimuscarinics Atropine Hysocine MI receptors Anitihistaminics Hydroxizine HI receptors Neurokinin-I antagonists Aprepitant Others Dexamethasone</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Heparin acts via which of the following adjuvants?", "options": [{"label": "A", "text": "Antithrombin III", "correct": true}, {"label": "B", "text": "Protein C", "correct": false}, {"label": "C", "text": "Protein S", "correct": false}, {"label": "D", "text": "Thrombomodulin", "correct": false}], "correct_answer": "A. Antithrombin III", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Antithrombin III</p>\n<p><strong>Highyeild:</strong></p><p>Heparin binds to antithrombin III (AT-III) and accelerate the rate at which it inhibits various coagulation proteases. Heparin is a sulfated polysaccharide with a molecular weight range of 3000 to 30,000 Da (mean, 15,000 Da). It produces its major anticoagulant effect by inactivating thrombin and activated factor X (factor Xa) through an AT-III -dependent mechanism. Heparin binds to AT-III through a high-affinity Penta saccharide, which is present on about a third of heparin molecules. For inhibition of thrombin, heparin must bind to both the coagulation enzyme and AT (scaffolding of thrombin molecule is required by the heparin), whereas binding to the enzyme is not required for inhibition of factor Xa (only conformational change is sufficient). Molecules of heparin with fewer than 18 saccharides lack the chain length to bridge between thrombin and AT and therefore are unable to inhibit thrombin.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Discontinuation of which of the following drugs can result in anxiety and insomnia?", "options": [{"label": "A", "text": "Venlafaxine", "correct": true}, {"label": "B", "text": "Imipramine", "correct": false}, {"label": "C", "text": "Valproate", "correct": false}, {"label": "D", "text": "Olanzapine", "correct": false}], "correct_answer": "A. Venlafaxine", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Venlafaxine</p>\n<p><strong>Highyeild:</strong></p><p>Sudden withdrawal of shorter acting antidepressants particularly SSRIs (paroxetine and sertraline) and SNRI (venlafaxine) can lead to discontinuation syndrome and troublesome side effects. These symptoms may include dizziness, headache, nervousness, nausea, anxiety, and insomnia. Out of the options provided, Venlafaxine is the best answer.</p>\n<p><strong>Table:</strong></p><p>#MANTRA CLASSIFICATION OF ANTIDEPRESSANT DRUGS 1) SSRIS: Citalopram, Escitalopram, Fluoxetine, Fluvoxamine, Paroxetine, Sertraline. 2) SNRIS: Duloxetine, Venlafaxine, Desvenlafaxine, Milnacipram. 3) SEROTONIN RECEPTOR ANTAGONIST: Mirtazapine, Nefazodone, Trazodone, Atomoxetine, Bupropion, Mianserin. 4) MAOIS: Phenelzine, Selegiline, Tranylcypromine, Moclobemide. 5) TCAS: Amitriptyline, Clomipramine, Doxepin, Imipramine, Trimipramine,Reboxetine,Amoxapine, Desipramine, Maprotiline, Nortriptyline, Protriptyline.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is not an adverse effect of escitalopram?", "options": [{"label": "A", "text": "Sialorrhea", "correct": true}, {"label": "B", "text": "Vivid dreams", "correct": false}, {"label": "C", "text": "Nausea", "correct": false}, {"label": "D", "text": "Anorgasmia", "correct": false}], "correct_answer": "A. Sialorrhea", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Sialorrhea</p>\n<p><strong>Highyeild:</strong></p><p>Sialorrhea is not a side effect of SSRIs. Following are the adverse effects of SSRIs (escitalopram is one of the SSRI): GI side effects: Nausea, vomiting, diarrhea (because of increased serotonergic tone in OIT) Sexual side effects: Diminished sexual function and interest, leading to loss of libido, delayed orgasm/anorgasmia or diminished arousal (because of increased serotonergic tone at the level of spinal cord and above). Others: Headache, insomnia, hypersomnia, irritability, weight gain, dizziness, paresthesia, etc., they can also lead to vivid dreams. Discontinuation syndrome can occur with shorter acting SSRIs like paroxetine and sertraline.</p>\n<p><strong>Table:</strong></p><p>#MANTRA SSRI possible side effects Appetite loss or Increase Weight gain, weight loss Nausea, Diarrhea Decreased libido, delayed ejaculation or anorgasmia (10-30%) Akasthisia -inner restlessness (rare, usually at start) Fatigue, sleepiness or sleeplessness (can use Benzos or newer sleep medications as needed short term) Long term use can cause apathy at high doses Can cause hypomania or mania in bipolar patients Dry mouth Hyponatremia/SIADH (rare) Vivid dreams Increase in suicidal ideation in adolescents QT prolongation</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "New drug recently approved for Amyotrophic Lateral Sclerosis is:", "options": [{"label": "A", "text": "Edaravone", "correct": true}, {"label": "B", "text": "Piracetam", "correct": false}, {"label": "C", "text": "Ceftriaxone", "correct": false}, {"label": "D", "text": "Doxycycline", "correct": false}], "correct_answer": "A. Edaravone", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Edaravone</p>\n<p><strong>Highyeild:</strong></p><p>Edaravone is a novel neuroprotective agent for the treatment of amyotrophic lateral sclerosis (ALS). The exact mechanism of action of Edaravone in the treatment of ALS is unknown, its therapeutic effect may be due to its known antioxidant properties; oxidative stress is a part of the process that kills neurons in patients with ALS. Piracetam is a nootropic agent used as off-label drug supplement to enhance memory (not currently approved by the US FDA for any indication). It is used in Europe. Russia, South America, and many other places to treat myoclonus. Ceftriaxone and doxycycline are antimicrobial agents. They are not indicated for the management of ALS.</p>\n<p><strong>Table:</strong></p><p>#MANTRA APPROVED DISEASE MODIFYING TREATMENTS FOR AMYOTROPHIC LATERAL SCLEROSIS Riluzole Edaravone a Dose 50 mg orally twice daily (suspension, tablet, or film) 60 mg/day IV on 10 days/month Mechanism of action Glutamate inhibition Free radical scavenger Side effects Anaphylaxis, hepatotoxic ity, neutropenia, inter- stitial lung disease, and pneumonitis Anaphylaxis, hyper- sensitivity, erythema multiforme, and intravenous adminis tration complications Efficacy in dinical trials 12-month survival was 74% with riluzole vs 58% with placebo At 24 weeks decline on ALSFRS was 2.49 points less with eda- ravone vs placebo \"Insurance companies will typically approve reimbursement of edaravone only for adults who have had ALS for 2 years or less and still have 80% FVC and score of at least 2 on every ALSFRS item. Abbreviations: ALSFRS, amyotrophic lateral sclerosis func- tional rating scale, FVC, functional vital capacity; IV, intravenous</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following drugs is not used in rheumatoid arthritis?", "options": [{"label": "A", "text": "Febuxostat", "correct": true}, {"label": "B", "text": "Leflunomide", "correct": false}, {"label": "C", "text": "Etanercept", "correct": false}, {"label": "D", "text": "Methotrexate", "correct": false}], "correct_answer": "A. Febuxostat", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Febuxostat</p>\n<p><strong>Highyeild:</strong></p><p>Febuxostat is used for the treatment of chronic gout. It is non-purine inhibitor (allopurinol is a purine analogue) of xanthine oxidase. It is more potent and selective than allopurinol. Leflunomide, methotrexate. and etanercept are DMARDs (Disease modifying anti-rheumatoid drugs) used for the management of rheumatoid arthritis (RA). ‚Äì  Etanercept is a genetically engineered fusion protein. It prevents binding of TNF-alpha from binding to its receptor, hence it is anti-TNF-alpha. ‚Äì  Leflunomide is dihydroorotate dehydrogenase (DHODH) inhibitor leading to decreased ribonucleotide synthesis. It leads to inhibition of T-cell proliferation and production of autoantibodies. ‚Äì  Methotrexate is one of the most commonly used DMARD for RA.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Class Names Anti-TNF-alpha therapies a. Etanercept (Enbrel) b. Infliximab (Remicade) c. Adalimumab (Humira) d. Certolizumab pegol (Cimzia) e. Golimumab (Simponi) Anti-CD20 monoclonal antibodies Rituximab (Mabthera) T cell co-stimulation inhibitor Abatacept (Orencia) Interleukin-6 inhibitors Tocilizumab (Actemra) Oral JAK inhibitor Tofacitinib (Xeljanz)</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following act through G protein coupled receptors?", "options": [{"label": "A", "text": "Ach Muscarinic receptors", "correct": true}, {"label": "B", "text": "Insulin receptors", "correct": false}, {"label": "C", "text": "Ach Nicotinic receptors", "correct": false}, {"label": "D", "text": "GABA- A receptors", "correct": false}], "correct_answer": "A. Ach Muscarinic receptors", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Ach Muscarinic receptors</p>\n<p><strong>Highyeild:</strong></p><p>MI, M2, M3, M4, and M5 are Ach Muscarinic receptors. They are G protein coupled receptors. MI and M3 act through Gq protein, activates IP3/DAG and increase cytosolic calcium while M2 receptors involve Gi protein, inhibits adenylyl cyclase and increases potassium conductance. Insulin receptors are a member of the ligand-activated receptor and tyrosine kinase family of transmembrane signalling proteins Ach Nicotinic receptors are ionotropic receptors or ion-channel coupled receptors GABA-A receptors are also ionotropic receptors or ion-channel coupled receptors. Glutamate receptors, glycine receptors are other examples of ionotropic receptors.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Muscarinic receptors (M-receptor) Nicotinic receptors (N-receptor) Locations smooth muscle, gland and cardiac muscle ‚ö´M--- smooth muscle, gland ‚ö´M1--- ganglia„ÄÅ gland ‚ö´M2--- heart skeletal muscle-- motor ending-plate (N2 N2), ganglia-postsynaptic membrane (N1), Effect inhibiting the cardiac muscle, exciting the smooth muscle & gland N2:exciting skeletal muscle, N1 exciting the postsynaptic neuron in ganglia Antagonist Atropine N1:hexamethonium N2:decamethonium</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Loading dose of a drug depends upon:", "options": [{"label": "A", "text": "Volume of distribution", "correct": true}, {"label": "B", "text": "Clearance of drug", "correct": false}, {"label": "C", "text": "Half-life", "correct": false}, {"label": "D", "text": "Bioavailability", "correct": false}], "correct_answer": "A. Volume of distribution", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Volume of distribution</p>\n<p><strong>Highyeild:</strong></p><p>Sometimes rapid achievement of desired plasma concentrations of drugs is needed to produce the prompt response (e.g., in serious infections or arrhythmias). When the time to reach steady state is long, as it is for drugs with long half-lives and having high volume of distribution (Vd) due to their tissue affinities, it may be desirable to administer a large dose (loading dose) to achieve the desired plasma levels rapidly. The volume of distribution is ‚Äòthe proportionality factor that relates the total amount of drug in the body to the concentration in the plasma (Cp). Loading dose = Vd √ó Desired steady state plasma concentration Loading dose can be given as single dose or multiple doses over a short time. E.g. in case of treatment of AF by digoxin (longer acting drug with high Vd), loading dose is must to saturate the tissues and to achieve desired plasma concentration rapidly (otherwise it would take about a week for digoxin to achieve the steady state plasma concentration). Loading dose of Chloroquine is also required to treat the malaria. On the other hand, maintenance dose is dependent of the clearance (Cl) as we have to maintain the steady state concentration in view of the volume of the plasma cleared of drug per unit time. Hence, equation for maintenance dose is Maintenance dose = CI √ó Desired steady state plasma concentration</p>\n<p><strong>Table:</strong></p><p>#MANTRA</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Therapeutic index is a measure of:", "options": [{"label": "A", "text": "Safety", "correct": true}, {"label": "B", "text": "Efficacy", "correct": false}, {"label": "C", "text": "Potency", "correct": false}, {"label": "D", "text": "Selectivity", "correct": false}], "correct_answer": "A. Safety", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Safety</p>\n<p><strong>Highyeild:</strong></p><p>The therapeutic index (TI) of a drug is the ratio of the dose that produces toxicity to the dose that produces a clinically desired or effective response in a population of individuals: Tl = TD50/ED50 Where TD50 = the drug dose that produces a toxic effect in 50% the population and ED50 = the drug dose that produces a therapeutic or desired response in 50% the population. TI is a measure of a drug‚Äôs safety, because a larger value indicates a wide margin between doses that are effective and doses that are toxic.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Narrow Therapeutic Index Drugs Wide Therapeutic Index Drugs Digoxin Ibuprofen Warfarin Acetaminophen Lithium Antihistamines Theophylline Most Antibiotics Cyclosporine Beta blockers Tacrolimus Multivitamins Gentamicin Proton pump inhibitors</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Manufacturer of a drug company labels the drug contains 500 mg paracetamol. On govt. analysis, it was found to contain only 200 mg of drug. Which type of drug it is known as?", "options": [{"label": "A", "text": "Counterfeit drug", "correct": true}, {"label": "B", "text": "Spurious drug", "correct": false}, {"label": "C", "text": "Adulterant drug", "correct": false}, {"label": "D", "text": "Unethical drug", "correct": false}], "correct_answer": "A. Counterfeit drug", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Counterfeit drug</p>\n<p><strong>Highyeild:</strong></p><p>According to the US FDA counterfeit medicine is fake medicine. It may be contaminated or contain the wrong or no active ingredient. They could have the right active ingredient but at the wrong dose. Counterfeit drugs are illegal and may be harmful to your health. In our question, the drug company labeled that the drug contains 500 mg of paracetamol but on analysis it contained only 200 mg of drug. Going with this definition, it has the right ingredient (paracetamol) but at a wrong dose (200 mg in place of 500 mg). Hence, this is a case of counterfeit medicine. WHO Definition: A counterfeit medicine is one which is deliberately and fraudulently mislabelled with respect to identity and/or source. Counterfeiting can apply to both branded and generic products and counterfeit products and may include products with the correct ingredients, wrong ingredients, without active ingredients, with insufficient quantity of active ingredients or with Jake packaging. Since drug in our question, i.e., paracetamol contains insufficient quantity (200 mg instead of 500 mg), again this qualifies for a counterfeit drug. Spurious/adulterated drugs: According to the CDSCO (drugs and cosmetic act 1940, rules 1945, amendment 5th December 2008) Spurious or imitation drug products are drug formulations manufactured concealing the true identity of the product and made to resemble another drug, especially some popular brand, to deceive the buyer and cash on the popularity of original product. The product may or may not contain the active ingredients. Spurious drugs are usually manufactured by unlicensed anti-social elements, but sometimes licensed manufacturers may also be involved. The adulterated drugs are those drugs which are found to contain an adulterant/substituted product or contaminated with filth rendering it injurious to health. In India, the penalty for manufacture of spurious or adulterated drugs has been enhanced to an imprisonment for a term which shall not be less than 10 years, but which may extend to imprisonment for life and shall also be liable to fine which shall not be less than ten lakh rupees or three times value of the drug confiscated, whichever is more. In certain cases, offences have been made cognizable and non-bailable.</p>\n<p><strong>Table:</strong></p><p>#MANTRA The Counterfeit Pharmaceutical Supply Chain Many counterfeit and substandard drugs are produced overseas, often in Southeast Asia, China, India, Nigeria, Russia, Mexico, Brazil and Latin America. Growing ancedotal evidence suggests that many substandard and \"gray\" pharmaceuticals are being produced in Western industrialized countries. Both licit and illicit products are funneled into the legitimate supply chain through freight forwarders, shipping companies, importers, diverters, tertiary and secondary wholesalers, and individual and online purchasers. Products may end up on the shelves of local pharmacies and legitimate online retailers, or may be marketed directly to consumers via phony internet pharmacies or through personal black markets. Patients may either unknowingly purchase counterfeit drugs from a legitimate retailer, or knowingly purchase illicit products at cut rate prices through the black market.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Hepatic First pass metabolism will be bypassed by the following routes of drug administration except:", "options": [{"label": "A", "text": "Oral", "correct": true}, {"label": "B", "text": "Sublingual", "correct": false}, {"label": "C", "text": "Intravenous", "correct": false}, {"label": "D", "text": "Subcutaneous", "correct": false}], "correct_answer": "A. Oral", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Oral</p>\n<p><strong>Highyeild:</strong></p><p>When we give a drug by Intravenous (IV) route, the drug enters the systemic circulation directly, bypassing the 1st pass metabolism (100% bioavailability). Oral route has certain disadvantages notably the 1st pass metabolism in liver before reaching the systemic circulation. Sublingual route has certain advantages, notably quick onset of action (e.g. nitro-glycerine in angina pectoris) and absorption through the buccal or sublingual mucosa, hence bypassing liver and 151 pass metabolism. Subcutaneous route also has the advantage of bypassing liver.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Enterohepatic Circulation Some of the molecules released into the bile are absorbed again in the small intestine and returned to the liver. These molecules are part of enterohepatic circulation.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "From which of the following routes, bioavailability of the drug is likely to be 100 percent?", "options": [{"label": "A", "text": "Intravenous", "correct": true}, {"label": "B", "text": "Subcutaneous", "correct": false}, {"label": "C", "text": "Intramuscular", "correct": false}, {"label": "D", "text": "Intradermal", "correct": false}], "correct_answer": "A. Intravenous", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Intravenous</p>\n<p><strong>Highyeild:</strong></p><p>T his is very simple question. When we give a drug by Intravenous (IV) route, the drug enters the systemic circulation directly, bypassing the 1st pass metabolism, so there is 100% bioavailability by this route. Absorption is also predictable by Intramuscular (i.m.) route, it is less variable as compared to oral and subcutaneous (s/c) route. But bioavailability is not 100 %. In sic route, absorption is smooth but slower as compared to iv and i.m. route. Again, bioavailability is not 100%. By intradermal (id) route, absorption is very slow and only a small volume of drug can be injected. In routes other than iv (i.m., s.c. and i.d.), the drug may precipitate at the site of injection, leading to their lesser bioavailability as compared to IV route.</p>\n<p><strong>Table:</strong></p><p>#MANTRA</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following parameter is used to assess the rate of drug absorption in plasma concentration graph?", "options": [{"label": "A", "text": "Tmax and Cmax", "correct": true}, {"label": "B", "text": "Cmax alone", "correct": false}, {"label": "C", "text": "Tmax alone", "correct": false}, {"label": "D", "text": "Area under the curve", "correct": false}], "correct_answer": "A. Tmax and Cmax", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Tmax and Cmax</p>\n<p><strong>Highyeild:</strong></p><p>From the plasma concentration graph, we obtain three important parameters: C max is the peak plasma concentration T max , i.e., time to attain the peak plasma concentration or C max AUC (Area under the curve) of plasma concentration time graph The 1st two parameters, i.e., C max and the T max are the indicators of the rate of absorption. The AUC represents the extent of absorption. It is calculated by the trapezoidal rule. Theses parameters are important to evaluate the bioequivalence and bioavailability of a generic/test drug as compared to that of the standard reference drugs.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Pharmacokinetic (PK) Implications for Subcutaneous (SC) Peptides and Drugs</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following drugs should be sold only on prescription of a registered medical practitioner?", "options": [{"label": "A", "text": "Schedule H drugs", "correct": true}, {"label": "B", "text": "Schedule X drugs", "correct": false}, {"label": "C", "text": "Schedule J drugs", "correct": false}, {"label": "D", "text": "Schedule Y drugs", "correct": false}], "correct_answer": "A. Schedule H drugs", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Schedule H drugs</p>\n<p><strong>Highyeild:</strong></p><p>SCHEDULE 